Market research
27R.F RaySearch Laboratories AB (publ)
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 489M
- P/E ratio
- 28.29
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 0.87
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Health Information Services
- ISIN
- SE0000135485
- Market cap
- 489M
- P/E ratio
- 28.29
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 0.87
About
About RaySearch Laboratories AB (publ)
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation* (Micro-RayStation), a software platform for planning and evaluation in small animal irradiation research; RayPlan, a treatment planning system; DrugLog, which verifies the identity and concentration of compounded injectables before administered to a patient; RayMigrate, allows users to convert Pinnacle patient data to RayStation format and/or to DICOM format; Machine Learning; and Liver Ablation Solutions. The company was founded in 2000 and is headquartered in Stockholm, Sweden.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 27R.F discussion.
5 years, 6 months ago
RaySearch Laboratories AB (publ) is currently in a long term uptrend where the price is trading 4.8% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.2.
RaySearch Laboratories AB (publ)'s total revenue sank by 49.2% to $119M since the same quarter in the previous year.
Its net income has dropped by 238.3% to $-26M since the same quarter in the previous year.
Finally, its free cash flow fell by 50.1% to $41M since the same quarter in the previous year.
Based on the above factors, RaySearch Laboratories AB (publ) gets an overall score of 2/5.